|
1
|
Seidah NG and Chrétien M: Proprotein and
prohormone convertases: a family of subtilases generating diverse
bioactive polypeptides. Brain Res. 848:45–62. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nagahama M, Taniguchi T, Hashimoto E, et
al: Biosynthetic processing and quaternary interactions of
proprotein convertase SPC4 (PACE4). FEBS Lett. 434:155–159. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mains RE, Berard CA, Denault JB, et al:
PACE4: a subtilisin-like endoprotease with unique properties.
Biochem J. 321:587–593. 1997.PubMed/NCBI
|
|
4
|
Jensen RA, Thompson ME, Jetton TL, et al:
BRCA1 is secreted and exhibits properties of a granin. Nat Genet.
12:303–308. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Walerych D, Napoli M, Collavin L and Del
Sal G: The rebel angel: mutant p53 as the driving oncogene in
breast cancer. Carcinogenesis. 33:2007–2017. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bassi DE, Zhang J, Cenna J, et al:
Proprotein convertase inhibition results in decreased skin cell
proliferation, tumorigenesis, and metastasis. Neoplasia.
12:516–526. 2010.
|
|
7
|
Lapierre M, Siegfried G, Scamuffa N, et
al: Opposing function of the proprotein convertases furin and PACE4
on breast cancer cells’ malignant phenotypes: role of tissue
inhibitors of metalloproteinase-1. Cancer Res. 67:9030–9034.
2007.PubMed/NCBI
|
|
8
|
D’Anjou F, Routhier S, Perreault JP, et
al: Molecular validation of PACE4 as a target in prostate cancer.
Transl Oncol. 4:157–172. 2011.PubMed/NCBI
|
|
9
|
Tsuji A, Sakurai K, Kiyokage E, et al:
Secretory proprotein convertases PACE4 and PC6A are heparin-binding
proteins which are localized in the extracellular matrix. Potential
role of PACE4 in the activation of proproteins in the extracellular
matrix. Biochim Biophys Acta. 1645:95–104. 2003. View Article : Google Scholar
|
|
10
|
Cheng M, Watson PH, Paterson JA, et al:
Pro-protein convertase gene expression in human breast cancer. Int
J Cancer. 71:966–971. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hubbard FC, Goodrow TL, Liu SC, et al:
Expression of PACE4 in chemically induced carcinomas is associated
with spindle cell tumor conversion and increased invasive ability.
Cancer Res. 57:5226–5231. 1997.PubMed/NCBI
|
|
12
|
Schalken JA, Roebroek AJ, Oomen PP, et al:
fur gene expression as a discriminating marker for small cell and
nonsmall cell lung carcinomas. J Clin Invest. 80:1545–1549. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fu Y, Campbell EJ, Shepherd TG and
Nachtigal MW: Epigenetic regulation of proprotein convertase PACE4
gene expression in human ovarian cancer cells. Mol Cancer Res.
1:569–576. 2003.PubMed/NCBI
|
|
14
|
Duguay SJ, Jin Y, Stein J, et al:
Post-translational processing of the insulin-like growth factor-2
precursor. Analysis of O-glycosylation and endoproteolysis. J Biol
Chem. 273:18443–18451. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bassi DE, Lopez De Cicco R, Cenna J, et
al: PACE4 expression in mouse basal keratinocytes results in
basement membrane disruption and acceleration of tumor progression.
Cancer Res. 65:7310–7319. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guttinger M, Sutti F, Panigada M, et al:
Epithelial V-like antigen (EVA), a novel member of the
immunoglobulin superfamily, expressed in embryonic epithelia with a
potential role as homotypic adhesion molecule in thymus
histogenesis. J Cell Biol. 141:1061–1071. 1998. View Article : Google Scholar
|
|
17
|
Dong S, Zhang Z and Takahara H:
Estrogen-enhanced peptidylarginine deiminase type IVgene (PADI4)
expression in MCF-7 cells is mediated estrogen
receptor-alpha-promoted transfactors activator protein-1, nuclear
factor-Y, and Sp1. Mol Endocrinol. 21:1617–1629. 2007. View Article : Google Scholar
|
|
18
|
Fu J, Bassi DE, Zhang J, et al: Enhanced
UV-induced skin carcinogenesis in transgenic mice overexpressing
proprotein convertases. Neoplasia. 15:169–179. 2013.PubMed/NCBI
|
